News
3d
MedPage Today on MSNAt Least 60% of Liver Cancers Tied to Preventable Risk FactorsSixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...
At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...
1d
The Hearty Soul on MSNDeficiency in Key Vitamin Linked to Liver DiseaseFatty liver disease is one of the fastest-growing health concerns worldwide, impacting roughly 32% of people worldwide, according to a 2022 systematic review. It is closely tied to rising rates of ...
MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.
2d
News Medical on MSNRising liver cancer rates highlight need for urgent action worldwideThe majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...
The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...
Higher cumulative exposure to uric acid is independently and dose-dependently associated with an increased risk for MASLD. Cumulative uric acid (UA) exposure is an independent risk factor for ...
The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...
Poor dietary habits and obesity are key contributors to non-alcoholic fatty liver disease (NAFLD).leading to inflammation and ...
In fact, heart disease is the most common cause of death among people who have metabolic dysfunction-associated steatotic liver disease (MASLD) (previously known as non-alcoholic liver disease).
MASLD stands for metabolic dysfunction-associated steatotic liver disease, and it’s a liver condition related to metabolic health. Taking steps like following a balanced diet, staying physically ...
The stigma of liver disease is all too common, whether it’s MASLD or other ones, like cirrhosis. One study published in 2022 found that 69% of patients with MASLD said they were stigmatized in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results